GHK-Cu, 50mg

GHK-Cu is a copper-binding peptide complex composed of the tripeptide glycine-histidine-lysine (GHK) and a copper ion. It occurs naturally in human plasma and has been studied in research settings for its interaction with cellular signaling pathways related to tissue dynamics, extracellular matrix regulation, and immune response.

Tissue and Skin Research

GHK-Cu has been investigated for its role in cellular processes associated with connective tissue and skin structure. Experimental studies have explored its interaction with pathways involved in collagen synthesis, extracellular matrix organization, and fibroblast activity. Research has also examined its association with signaling mechanisms that influence cellular turnover and structural protein regulation under controlled conditions.

In tissue-related models, GHK-Cu has been studied for its interaction with pathways associated with angiogenesis, cellular proliferation, and wound-related signaling processes. These findings are derived from preclinical models and remain context-dependent.

Pulmonary and Inflammatory Research

GHK-Cu has been examined in experimental models of pulmonary function and inflammatory signaling. Studies have explored its interaction with pathways related to oxidative stress, cytokine expression, and extracellular matrix remodeling in lung tissue under controlled conditions. These observations are based on laboratory and animal studies and require further validation.

Neurological Research

Research has investigated GHK-Cu in models related to neurobiological function and cellular stress responses. Experimental findings suggest potential interactions with pathways involved in protein aggregation, oxidative balance, and neuronal signaling. These studies are preliminary and not fully characterized across different neurological models.

Antimicrobial Research

GHK-Cu has also been studied in laboratory models for its interaction with microbial systems. Experimental work has explored its association with antibacterial activity in controlled environments, including studies utilizing nanoparticle formulations to assess stability and cellular interaction.

Gene Expression and Cellular Signaling

GHK-Cu has been widely examined for its influence on gene expression and intracellular signaling pathways. Research suggests it may interact with regulatory mechanisms involved in cellular maintenance, stress response, and tissue remodeling. These findings are based on preclinical investigations and remain under ongoing study. 

GHK-Cu is not approved by the U.S. Food and Drug Administration for human use, and its safety, efficacy, and pharmacological profile have not been established in approved FDA clinical trials. It is not intended to diagnose, treat, cure, or prevent any disease.